<DOC>
	<DOCNO>NCT00654940</DOCNO>
	<brief_summary>The purpose study ass whether cross-over type study design post-traumatic neuropathic patient used assess activity potential analgesic agent</brief_summary>
	<brief_title>A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients</brief_title>
	<detailed_description>Methodology study evaluate cross-over study design post-traumatic neuropathic pain patient .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients require diagnosis posttraumatic peripheral neuropathic pain ( NeP ) , include postsurgical NeP NeP due peripheral nerve injury , last least 3 month follow traumatic event . Patients screen week must complete ≥ 4 daily pain score average daily pain score ≥ 4 . Female patient childbearing potential must negative urine pregnancy test Screening practice acceptable form contraception . Patients neuropathic pain ( NeP ) due trauma ; e.g . patient trigeminal neuralgia , central pain , complex region pain syndrome type I , phantom limb pain , radiculopathy , painful diabetic neuropathy postherpetic neuralgia patient coexist pain differentiate NeP peripheral origin . Patients previously fail respond pregabalin total daily dose equal great 300 mg intolerant dos . Patients previously fail respond gabapentin total daily dose equal great 1800 mg . Patients type history malignancy , except either ongoing treatment least 6 month basal cell carcinoma ; patient history brain spinal tumor exclude . Patients currently ongoing litigation related injury affect pain symptomatology .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>